DOCSLIB.ORG

Subchapter R—Toxic Substances Control Act

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Subchapter R—Toxic Substances Control Act SUBCHAPTER R—TOXIC SUBSTANCES CONTROL ACT PART 700—GENERAL nism (each being assigned a separate MCAN number by EPA) as a result of a Subparts A–B [Reserved] prenotice agreement with EPA. Consolidated premanufacture notice or Subpart C—Fees consolidated PMN means any PMN sub- mitted to EPA that covers more than Sec. one chemical substance (each being as- 700.40 Purpose and applicability. signed a separate PMN number by 700.41 Radon user fees. 700.43 Definitions. EPA) as a result of a prenotice agree- 700.45 Fee payments. ment with EPA (See 48 FR 21734). 700.49 Failure to remit fees. Exemption application means any ap- plication submitted to EPA under sec- AUTHORITY: 15 U.S.C 2625 and 2665, 44 U.S.C. 3504. tion 5(h)(2) of the Act. Exemption notice means any notice SOURCE: 53 FR 31252, Aug. 17, 1988, unless submitted to EPA under § 723.175 of this otherwise noted. chapter. Final product means a new chemical Subparts A–B [Reserved] substance (as ‘‘new chemical sub- stance’’ is defined in § 720.3 of this Subpart C—Fees chapter) that is manufactured by a per- son for distribution in commerce, or § 700.40 Purpose and applicability. for use by the person other than as an (a) Purpose. The purpose of this sub- intermediate. part is to collect fees from manufactur- Intermediate premanufacture notice or ers, importers, and processors who sub- intermediate PMN means any PMN sub- mit notices and applications to EPA mitted to EPA for a chemical sub- under section 5 of the Toxic Substances stance which is an intermediate (as Control Act (15 U.S.C. 2604) to defray ‘‘intermediate’’ is defined in § 720.3 of part of EPA’s cost of administering the this chapter) in the production of a Act. final product, provided that the PMN (b) Applicability. This subpart applies for the intermediate is submitted to to all manufacturers, importers, and EPA at the same time as, and together processors who submit certain notices with, the PMN for the final product and applications to EPA under section and that the PMN for the intermediate 5 of the Act. identifies the final product and de- scribes the chemical reactions leading § 700.41 Radon user fees. from the intermediate to the final User fees relating to radon pro- product. If PMNs are submitted to EPA ficiency programs authorized under the at the same time for several intermedi- Toxic Substances Control Act appear ates used in the production of a final at 40 CFR part 195. product, each of those is an inter- mediate PMN if they all identify the [59 FR 13177, Mar. 18, 1994] final product and every other associ- ated intermediate PMN and are sub- § 700.43 Definitions. mitted to EPA at the same time as, Definitions in section 3 of the Act (15 and together with, the PMN for the U.S.C. 2602), as well as definitions con- final product. tained in §§ 704.3, 720.3, and 725.3 of this Joint submitters means two or more chapter, apply to this subpart unless persons who submit a section 5 notice otherwise specified in this section. In together. addition, the following definitions Microbial commercial activity notice or apply: MCAN means any notice for microorga- Consolidated microbial commercial ac- nisms submitted to EPA pursuant to tivity notice or consolidated MCAN section 5(a)(1) of the Act in accordance means any MCAN submitted to EPA with subpart D of part 725 of this chap- that covers more than one microorga- ter. 5 VerDate Mar<15>2010 16:57 Aug 29, 2011 Jkt 223174 PO 00000 Frm 00015 Fmt 8010 Sfmt 8010 Q:\40\40V31.TXT ofr150 PsN: PC150 § 700.45 40 CFR Ch. I (7–1–11 Edition) Person means a manufacturer, im- (iv) Exemption applications. Persons porter, or processor. shall remit a fee of $2,500 for each ex- Premanufacture notice or PMN means emption application submitted under any notice submitted to EPA pursuant section 5(h)(2) of the Act. to section 5(a)(1)(A) of the Act in ac- (v) Exemption notices. Persons shall cordance with part 720 of this chapter remit a fee of $2,500 for each exemption or § 723.250 of this chapter. notice submitted under § 723.175 of this Section 5 notice means any PMN, con- chapter. solidated PMN, intermediate PMN, sig- (vi) MCAN and consolidated MCAN. nificant new use notice, exemption no- Persons shall remit a fee of $2,500 for tice, exemption application, any MCAN each MCAN or consolidated MCAN sub- or consolidated MCAN submitted under mitted. section 5 of the Act. (c) No fee required. Persons are ex- Significant new use notice means any empt from remitting any fee for sub- notice submitted to EPA pursuant to missions under §§ 720.38, 723.50, and sub- section 5(a)(1)(B) of the Act in accord- parts E, F, and G of part 725 of this ance with part 721 of this chapter. chapter. Small business concern means any per- (d) Joint submitters. Joint submitters son whose total annual sales in the per- of a section 5 notice are required to son’s fiscal year preceding the date of remit the appropriate fee identified in the submission of the applicable sec- paragraph (b) of this section for each tion 5 notice, when combined with section 5 notice regardless of the num- those of the parent company (if any), ber of joint submitters for that notice. are less than $40 million. To qualify for the fee identified in paragraph (b)(1) of this section, each [53 FR 31252, Aug. 17, 1988, as amended at 62 joint submitter of a section 5 notice FR 17931, April 11, 1997] must qualify as a small business con- § 700.45 Fee payments. cern under § 700.43. (e) Remittance procedure. (1) Each re- (a) Persons who must pay fees. Persons mittance under this section shall be in submitting a section 5 notice to EPA United States currency and shall be shall remit for each such notice the ap- paid by money order, bank draft, wire propriate fee identified in paragraph transfer, Pay.gov service provided (b) of this section in accordance with through the Department of the Treas- the procedures in paragraph (e) of this ury, or check drawn to the order of the section. Environmental Protection Agency. (b) Fees. Persons shall remit fee pay- (2) Each paper remittance shall be ments to EPA as follows: sent to the Environmental Protection (1) Small business concerns. Small Agency, Washington Finance Center, business concerns shall remit a fee of Toxic Substances Control Act User $100 for each section 5 notice sub- Fees, P.O. Box 979073, St. Louis, MO mitted. 63197–9000. (2) Others. Persons other than small (3) Persons who submit a TSCA sec- business concerns shall remit fees ac- tion 5 notice shall place an identifying cording to the type of section 5 notice number and a payment identity num- as follows: ber on the front page of each TSCA sec- (i) Premanufacture notices and consoli- tion 5 notice submitted. The identi- dated premanufacture notices. Persons fying number must include the letters shall remit a fee of $2,500 for each PMN ‘‘TS’’ followed by a combination of 6 or consolidated PMN submitted. numbers (letters may be substituted (ii) Intermediate premanufacture no- for some numbers). The payment iden- tices. Persons shall remit a fee of $1,000 tity number may be a check number, a for each intermediate PMN. However, wire transfer number, or a ‘‘Pay.gov’’ for the PMN for the final product the transaction number used to transmit person shall submit the fee in para- the user fee. The same TS number and graph (b)(2)(i) of this section. the submitter’s name must appear on (iii) Significant new use notices. Per- the corresponding fee remittance under sons shall remit a fee of $2,500 for each this section. If a remittance applies to significant new use notice submitted. more than one TSCA section 5 notice, 6 VerDate Mar<15>2010 16:57 Aug 29, 2011 Jkt 223174 PO 00000 Frm 00016 Fmt 8010 Sfmt 8010 Q:\40\40V31.TXT ofr150 PsN: PC150 Environmental Protection Agency § 700.45 the person shall include the name of the fee specified in 40 CFR 700.45(b).’’ the submitter and a new TS number for under ‘‘CERTIFICATION’’ on page 2 of each TSCA section 5 notice to which the Premanufacture Notice for New the remittance applies, and the amount Chemical Substances (EPA Form 7710– of the remittance that applies to each 25). notice. Any remittance not having the (ii) Each person who remits a fee identifying name and numbers de- identified in paragraph (b)(2) of this scribed in this paragraph will be re- section for an exemption application turned to the remitter. under TSCA section 5(h)(2) shall insert (4)(i) Each person who remits the fee a check mark for the statement, ‘‘The identified in paragraph (b)(1) of this company named in part 1, section A section for a PMN, consolidated PMN, has remitted the fee specified in 40 CFR intermediate PMN, or significant new 700.45(b).’’ in the exemption applica- use notice shall insert a check mark tion. for the statement, ‘‘The company (iii) Each person who remits the fee named in part 1, section A is a small identified in paragraph (b)(2) of this business concern under 40 CFR 700.43 section for an exemption notice under and has remitted a fee of $100 in ac- § 723.175 of this chapter shall include cordance with 40 CFR 700.45(b).’’ under ‘‘CERTIFICATION’’ on page 2 of the the words, ‘‘Each company identified in Premanufacture Notice for New Chem- this notice has remitted a fee of $2,500 ical Substances (EPA Form 7710–25).
Load more

Recommended publications
  • Chemical and Pharmacological Potential of Various Substituted Thiazine Derivatives
    J. Pharm. Appl. Chem., 1, No. 2, 49-64 (2015) 49 Journal of Pharmaceutical and Applied Chemistry An International Journal http://dx.doi.org/10.12785/jpac/010203 Chemical and Pharmacological Potential of Various Substituted Thiazine Derivatives Mohammad Asif*. Department of Pharmacy, GRD (PG) Institute of Management & Technology, 248009, Dehradun, (Uttarakhand), India. Received: 20 May 2015, Revised: 13 Jul. 2015, Accepted: 23 Jul. 2015. Published online: 1 Sep. 2015. Abstract: Heterocyclic compounds have strong interest in pharmaceutical research area because of their useful pharmacological activities. Heterocyclic compounds are abundant in nature and have acquired more importance because their structural subunits are exhibit in various natural products such as vitamins, hormones, antibiotics etc. The multifaceted chemical potential of 1,3-thiazine- a six membered species containing nitrogen and sulphur in the ring has led to unabated research in their synthetic methodologies. Thiazines are six membered heterocyclic compounds which have promising pharmacological activities which have drawn the attention of scientists and researchers. It is present in the fused form with β-lactam ring in major class of antibiotics like cephalosporins which shows the prevalence of thiazines. Thiazine compounds possess variety of pharmacological activities like anti-microbial, anti-mycobacterial, antifungal, antiviral, antitumor, antipsychotic, anti-inflammatory etc. The significance of thiazine derivatives has potential pharmacological moiety and future of these derivatives in the field of drug research. Some of the pharmacological activities are briefly summarized. This article summarizes various chemical reactions like condensation, cyclo-addition, ring transformations etc. The review focuses on thethiazine derivatives with potential activities that are now in development. Keywords: 1,3-Thiazine, antimicrobial, biological activities, heterocyclic compounds, β-lactam ring, cephalosporins.
    [Show full text]
  • STOUT: SMILES to IUPAC Names Using Neural Machine Translation Kohulan Rajan1, Achim Zielesny2 & Christoph Steinbeck1*
    STOUT: SMILES to IUPAC names using Neural Machine translation Kohulan Rajan1, Achim Zielesny2 & Christoph Steinbeck1* 1Institute for Inorganic and Analytical Chemistry, Friedrich-Schiller-University Jena, Lessingstr. 8, 07743 Jena, Germany 2Institute for Bioinformatics and Chemoinformatics, Westphalian University of Applied Sciences, August-Schmidt-Ring 10, D-45665 Recklinghausen, Germany *Corresponding author email: [email protected] Abstract Chemical compounds can be identified through a graphical depiction, a suitable string representation, or a chemical name. A universally accepted naming scheme for chemistry was established by the International Union of Pure and Applied Chemistry (IUPAC) based on a set of rules. Due to the complexity of this rule set a correct chemical name assignment remains challenging for human beings and there are only a few rule-based cheminformatics toolkits available that support this task in an automated manner. Here we present STOUT (SMILES-TO-IUPAC-name translator), a deep-learning neural machine translation approach to generate the IUPAC name for a given molecule from its SMILES string as well as the reverse translation, i.e., predicting the SMILES string from the IUPAC name. The open system demonstrates a test accuracy of about 90% correct predictions, also incorrect predictions show a remarkable similarity between true and predicted compounds. Graphical Abstract Keywords: Neural Machine Translation, chemical language, IUPAC names, SMILES, DeepSMILES, SELFIES, deep neural network, attention mechanism, recurrent neural network 1 Introduction Assigning names to chemical compounds so that an author can refer to them in the text of a scientific article, book or a patent has a long history. In the early days and even still today, such names were often chosen based on physicochemical or perceptible properties, but also named after species, people, named after fictional characters, related to sex, bodily functions, death and decay, religion or legend, or other [1].
    [Show full text]
  • United States Patent (19) 11 Patent Number: 5,952,316 Fujita Et Al
    USOO595231.6A United States Patent (19) 11 Patent Number: 5,952,316 Fujita et al. (45) Date of Patent: Sep. 14, 1999 54) 2-AMINO-1,3-PROPANEDIOL COMPOUND 4-6932O 3/1992 Japan . AND IMMUNOSUPPRESSANT 4-173723 6/1992 Japan . 4-224.548 8/1992 Japan . 75 Inventors: Tetsuro Fujita, Muko; Shigeo Sasaki; 5–78294 3/1993 Japan . Masahiko Yoneta, both of Kobe; 92/16236 A2 10/1982 WIPO. Tadashi Mishina, Iruma; Kunitomo OTHER PUBLICATIONS Adachi, Iruma; Kenji Chiba, Iruma, all of Japan Merck Index, No. 460 (2-Amino-2-methyl-1,3-propane diol) p. 73 (1989). 73 Assignees: Yoshitomi Pharmaceutical Industries, Bair et al., J. Med. Chem., “1-Pyrenylmethyl)amino alco Ltd., Osaka; Taito Co., Ltd., Tokyo, hols, a New Class Antitumor DNA Intercalators. Discovery both of Japan and Initial Amine Side Chain Structure-Activity Studies”, 1990, 33, pp. 2385-2393. 21 Appl. No.: 08/911,602 Shetty et al., J. Org. Chem, Nov. 1960, pp. 2057-2059. Derwent Abstract of Japan Patent Unexamined Pub. No. 22 Filed: Aug. 14, 1997 416/1987 published Jan. 1986. Derwent abstract of Japan Patent Unexamined Pub. No. Related U.S. Application Data 192962/1984 published Nov. 1984. Merck Index, 11th Edition, No. 9684 (Tromethamine), pp. 60 Continuation of application No. 08/478,834, Jun. 7, 1995, 1536–1537 (1989). abandoned, which is a division of application No. 08/244, Derwent abstract of Japan Patent Unexamined Pub. 104087/ 942, Jun. 17, 1994, Pat. No. 5,604,229. 1989 published Apr., 1989. 30 Foreign Application Priority Data Rembarz et al., J. Prakt.
    [Show full text]
  • WO 2018/075871 Al 26 April 2018 (26.04.2018) W !P O PCT
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2018/075871 Al 26 April 2018 (26.04.2018) W !P O PCT (51) International Patent Classification: A61K 31/4035 (2006.01) C07C 69/00 (2006.01) CI2Q 1/68 (2018.01) (21) International Application Number: PCT/US2017/057553 (22) International Filing Date: 20 October 20 17 (20. 10.201 7) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 62/41 1,384 2 1 October 2016 (21 .10.2016) US (71) Applicant: THE BROAD INSTITUTE, INC. [US/US]; 415 Main Street, Cambridge, MA 02142 (US). (72) Inventor; and (71) Applicant: VACCA, Joseph, P. [US/US]; c/o The Broad Institute, Inc., 415 Main Street, Cambridge, MA 02142 _ (US). = (74) Agent: HUNTER-ENSOR, Melissa; c/o Greenberg Trau- = rig LLP, One International Place, Boston, MA 021 10 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, = AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, = CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, ≡ DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, = HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, = KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, = MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, ≡ OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, = SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, ≡ TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
    [Show full text]
  • Heterocyclic Compound
    Heterocyclic compound . Pyridine, a heterocyclic compound cyclo-octasulfur, a homocyclic compound A heterocyclic compound or ring structure is a cyclic compound that has atoms of at least two different elements as members of its ring(s).[1] Heterocyclic chemistry is the branch of chemistry dealing with the synthesis, properties and applications of these heterocycles. In contrast, the rings of homocyclic compounds consist entirely of atoms of the same element. Although heterocyclic compounds may be inorganic, most contain at least one carbon. While atoms that are neither carbon nor hydrogen are normally referred to in organic chemistry as heteroatoms, this is usually in comparison to the all-carbon backbone. But this does not prevent a compound such as borazine (which has no carbon atoms) from being labelled "heterocyclic". IUPAC recommends the Hantzsch-Widman nomenclature for naming heterocyclic compounds. Classification based on electronic structure Heterocyclic compounds can be usefully classified based on their electronic structure. The saturated heterocycles behave like the acyclic derivatives. Thus, piperidine and tetrahydrofuran are conventional amines and ethers, with modified steric profiles. Therefore, the study of heterocyclic chemistry focuses especially on unsaturated derivatives, and the preponderance of work and applications involves unstrained 5- and 6-membered rings. Included are pyridine, thiophene, pyrrole, and furan. Another large class of heterocycles are fused to benzene rings, which for pyridine, thiophene, pyrrole, and furan arequinoline, benzothiophene, indole, and benzofuran, respectively. Fusion of two benzene rings gives rise to a third large family of compounds, respectively the acridine, dibenzothiophene, carbazole, anddibenzofuran. The unsaturated rings can be classified according to the participation of the heteroatom in the pi system.
    [Show full text]
  • Frequency and Importance of Six Functional Groups That Play a Role in Drug Discovery
    BIOSCIENCES BIOTECHNOLOGY RESEARCH ASIA, September 2018. Vol. 15(3), p. 541-548 Frequency and Importance of Six Functional Groups that Play a Role in Drug Discovery Sholeh Maslehat, Soroush Sardari* and Mahboube Ganji Arjenaki 1Drug Design and Bioinformatics Unit, Department of Medical Biotechnology, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran http://dx.doi.org/10.13005/bbra/2659 (Received: 05 July 2018; accepted: 18 September 2018) Small molecules are composed of chemical functional groups; they are sets of connected atoms or atom groups that determine properties and reactivity of the parent molecule. DrugBank is a rich source of information that containing molecular data about small molecules, their mechanisms, pharmaceutical interaction and targets. In this study, After collecting data of small drug molecules from DrugBank database and classifying them in different categories based on their mechanism of action, the therapeutic properties of the molecules were recorded. Finally, the functional group from the pharmaceutical structures were elucidated and registered for each group. The functional groups were divided into five distinct groups in drug design, and a correlation between identified functional group to pharmaceutical structure were indicated according to the classified functional groups of small molecule and drug categories; then defined their frequency in categories, at high abundant functional group present in categories reported. The most frequent rings were benzene and cyclohexane; the common acid functionality had been acetate (carboxy-); three most repeated saturated heterocyles are piperidine, piperazine and azetidine; among the unsaturated heterocyles, pyridine, imidazole and indole are noticed; This database, that may be guidance for researchers with the aim at designing new drugs.
    [Show full text]
  • 20 October 2011 (20.10.2011) V I A
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date r /1 1 20 October 2011 (20.10.2011) V I A (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every C12N 15/10 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, (21) International Application Number: CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, PCT/DK20 11/00003 1 DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, 16 April 201 1 (16.04.201 1) KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, (25) Filing Language: English NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, (26) Publication Language: English SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: 61/325,1 60 16 April 2010 (16.04.2010) US (84) Designated States (unless otherwise indicated, for every PA 2010 70149 16 April 2010 (16.04.2010) DK kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, (71) Applicant (for all designated States except US): ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, TJ, NUEVOLUTION A S [DK/DK]; R0nnegade 8, 5, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, DK-2100 Copenhagen (DK).
    [Show full text]
  • | Hai Lala at Matarun Amor a Halaman Nati
    |HAI LALA AT MATARUNUS009815847B2 AMOR A HALAMAN NATI (12 ) United States Patent ( 10 ) Patent No. : US 9 , 815 ,847 B2 Reddy et al. ( 45 ) Date of Patent : Nov . 14 , 2017 ( 54 ) PYRIMIDINE COMPOUNDS AS KINASE ( 56 ) References Cited INHIBITORS U . S . PATENT DOCUMENTS @(71 ) Applicant : Icahn School of Medicine at Mount 2004 / 0180914 AL 9 / 2004 Batchelor Sinai, New York , NY (US ) 2010 /0099691 AL 4 /2010 Boice 2013 / 0158057 A1 6 / 2013 Baker -Glenn @( 72 ) Inventors: M . V . Ramana Reddy , Blue Bell , PA 2014 /0045840 A1 2 /2014 Zhang (US ) ; E . Premkumar Reddy, Villanova , PA (US ) FOREIGN PATENT DOCUMENTS @(73 ) Assignee : Icahn School of Medicine at Mount EP 1364950 AL 11 /2003 JP 2009149618 A 7 / 2009 Sinai, New York , NY (US ) WO 98 / 33798 AL 8 / 1998 WO 01/ 55148 AL 8 / 2001 @( * ) Notice : Subject to any disclaimer , the term of this WO 0155147 A1 8 /2001 patent is extended or adjusted under 35 WO WO 2007 / 138974 * 12 / 2007 U . S . C . 154 ( b ) by 21 days . WO 2011/ 075616 AL 6 / 2011 WO 2011090666 A2 7 / 2011 WO 2012 /018540 A1 2 /2012 (21 ) Appl. No. : 14 /775 , 917 WO 2012 / 149567 AL 11 / 2012 ( 22 ) PCT Filed : Mar . 13 , 2014 OTHER PUBLICATIONS ( 86 ) PCT No .: PCT/ US2014 /026236 International Search Report for PCT/ US14 / 26236 dated Jun . 20 , $ 371 ( c ) ( 1 ) , 2014 . 3 pages . Pubchem SureCN4933440 , CID 10080432 , pp . 1 - 5 , Create Date : ( 2 ) Date : Sep . 14 , 2015 Oct. 25 , 2006 ; p . 1 ; [ retrieved on May 27 , 2014 ) . Retrieved from the Internet : , 25 /22 - 24 , 27 -29 , 90 -92 < URL : http : // pubchem .ncbi .
    [Show full text]
  • Naming and Indexing of Chemical Substances for Chemical Abstractstm
    Naming and Indexing of Chemical Substances for Chemical AbstractsTM 2007 Edition A publication of Chemical Abstracts Service Published by the American Chemical Society Naming and Indexing of Chemical Substances for Chemical AbstractsTM A publication of Chemical Abstracts Service Published by the American Chemical Society Copyright © 2008 American Chemical Society All Rights Reserved. Printed in the USA Inquiries concerning editorial content should be sent to: Editorial Office, Chemical Abstracts Service, 2540 Olentangy River Road, P.O. Box 3012, Columbus, Ohio 43210-0012 USA SUBSCRIPTION INFORMATION Questions about CAS products and services should be directed to: United States and Canada: CAS Customer Care Phone: 800-753-4227 (North America) 2540 Olentangy River Road 614-447-3700 (worldwide) P.O. Box 3012 Fax: 614-447-3751 Columbus, Ohio 43210-0012 USA E-mail: [email protected] Japan: JAICI (Japan Association for International Phone: 81-3-5978-3621 Chemical Information) Fax: 81-3-5978-3600 6-25-4 Honkomagome E-mail: [email protected] Bunkyo-ku, Tokyo Japan, 113-0021 Countries not named above: Contact CAS Customer Care, 2540 Olentangy River Road, P.O. Box 3012, Columbus, Ohio 43210-0012 USA; Telephone 614-447-3700; Fax 614-447-3751; E-mail [email protected]. For a list of toll-free numbers from outside North America, visit www.cas.org. 1 Naming and Indexing of Chemical Substances for Chemical Abstracts 2007 ¶ 102 NAMING AND INDEXING OF CHEMICAL SUBSTANCES 101. Foreword. Although the account which follows describes in consid- zwitterions (inner salts, sydnones). The changes for the Fourteenth (1997- erable detail the selection of substance names for Chemical Abstracts (CA) in- 2001) Collective Index period affect coordination nomenclature, stereochemi- dexes, it is not a nomenclature manual.
    [Show full text]
  • Tetrahydro-1, 4-Thiazine-3, 5-Dione
    molbank Short Note Tetrahydro-1,4-thiazine-3,5-dioneShort Note Tetrahydro-1,4-thiazine-3,5-dione R. Alan Aitken * , Alexandra M. Z. Slawin and Pei-pei Yeh R.EaStCHEM Alan Aitken School *, Alexandra of Chemistry, M. University Z. Slawin of Stand Andrews, Pei-pei North Yeh Haugh, St Andrews Fife KY16 9ST, UK; [email protected] (A.M.Z.S.); [email protected] (P.-p.Y.) EaStCHEM School of Chemistry, University of St Andrews, North Haugh, St Andrews Fife KY16 9ST, UK; * Correspondence: [email protected]; Tel.: +44-1334-463865 [email protected] (A.M.Z.S.); [email protected] (P.-p.Y.) * Correspondence: [email protected]; Tel.: +44-1334-463865 Received: 30 November 2018; Accepted: 12 December 2018; Published: 13 December 2018 Received: 30 November 2018; Accepted: 12 December 2018; Published: date Abstract: The X-ray structure of the title compound contains eight molecules in the unit cell which formAbstract: the basisThe X-ray of a herringbone structure of arrangement the title compound of hydrogen contains bonded eight ribbons. molecules in the unit cell which form the basis of a herringbone arrangement of hydrogen bonded ribbons. Keywords: tetrahydro-1,4-thiazine-3,5-dione; X-ray structure; hydrogen bonding Keywords: tetrahydro-1,4-thiazine-3,5-dione; X-ray structure; hydrogen bonding 1. Introduction The simplesimple heterocyclic heterocyclic compound compound tetrahydro-1,4-thiazine-3,5-dione tetrahydro-1,4-thiazine-3,5-dione (or thiomorpholine-3,5-dione) (or thiomorpholine-3,5- 1dione), the cyclic 1, the imide cyclic of imide thiodiglycolic of thiodiglycolic acid 2, was acid first 2 prepared, was first in prepared 1948 [1], andin 1948 IR and [1], NMR and spectroscopicIR and NMR dataspectroscopic were reported data were in 2001 reported [2].
    [Show full text]